๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

More bad news on Clostridium difficile in inflammatory bowel disease

โœ Scribed by Da Hea Seo; Christian D. Stone


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
51 KB
Volume
15
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Temporal trends in disease outcomes rela
โœ Ashwin N. Ananthakrishnan; Emily L. McGinley; Kia Saeian; David G. Binion ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB ๐Ÿ‘ 2 views

Background: Clostridium difficile has emerged as an important pathogen in patients with inflammatory bowel disease (IBD) and is associated with increased morbidity and mortality. No studies have examined the temporal change in severity of C. difficile infection (CDI) complicating IBD. Methods: Usin

Recurrence rate of clostridium difficile
โœ Judith R. Kelsen; Jason Kim; Dan Latta; Sarah Smathers; Karin L. McGowan; Theodo ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 178 KB ๐Ÿ‘ 2 views

## Background: The incidence and associated morbidity of Clostridium difficile (CD) infection has been increasing at an alarming rate in North America. Clostridium difficile-associated diarrhea (CDAD) is the leading cause of nosocomial diarrhea in the USA. Patients with CDAD have longer average ho

Practice of gastroenterologists in treat
โœ Henit Yanai; Geoffrey C. Nguyen; Laura Yun; Oscar Lebwohl; Udayakumar Navaneetha ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 242 KB ๐Ÿ‘ 1 views

## Background: The optimal management of clostridium difficile infection (cdi) in flaring inflammatory bowel disease (ibd) patients has not been defined. limited data suggest that coadministration of immunomodulators (im) with antibiotics (ab) results in a worse outcome. we investigated the prevale